A Rare Genomics Initiative
A Rare Genomics Institute Initiative
What is RareWear?
The RareWear program connects rare disease patients to medical device providers to offer free devices to help patients better monitor and manage their condition. RareWear is an ongoing program and patients are welcome to apply throughout the year.
Why RareWear?
Research and product development for rare diseases traditionally focuses more more on drugs and biological products. RareWear seeks to fill the gap for rare disease patients in need of monitoring devices to help manage their condition. The program benefits both patients and sponsoring companies alike - patients receive devices they normally don’t have access to and sponsors will gain a better understanding of how their products can help an important patient population. To learn more, read our blog post here.
How Does it Work?
Patients will be supported through the device matching process from a member of Rare Genomics Patient advocacy team. Once matched, Rare Genomics will connect patients to one of RareWear’s sponsoring companies to provide a device free of charge. Devices will be provided based on patient need and availability through the duration of the program.
Conditions RareWear seeks to support include but are not limited to:
The RareWear team is here to help you get started!
Rare genomics is continually working to keep up with demand for RareWare device matches. Submit an application today to add your name to the candidate list and be matched as a Rarewear recipient as soon as possible when a device becomes available.
Washington, D.C. Aug 2 2023. The Rare Genomics Institute (RG) is pleased to announce that Bodimetrics, a medical device company that specializes in wearable ring oximeter that is accurate in all skin tones, will continue their support of the RG RareWear program by donating 40 circul+ smart rings to allow patients with cardiac, respiratory, and other conditions, as well as their families and clinicians, to monitor metrics relevant to their disease area and benefit from the real-time information these devices provide.